Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam
- PMID: 1854181
- PMCID: PMC245140
- DOI: 10.1128/AAC.35.5.983
Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam
Abstract
Oral and parenteral administration of aztreonam and oral administration of tigemonam to conventional mice caused a decrease in the number of aerobic gram-negative rods in the feces. Oral treatment with high doses of aztreonam (greater than or equal to 25 mg/kg/day) and tigemonam (100 mg/kg/day) adversely influenced colonization resistance, whereas oral treatment with lower doses of the monobactams or parenteral treatment with aztreonam did not.
Similar articles
-
Tigemonam, an oral monobactam.Antimicrob Agents Chemother. 1988 Jan;32(1):84-91. doi: 10.1128/AAC.32.1.84. Antimicrob Agents Chemother. 1988. PMID: 3279906 Free PMC article.
-
Comparative in-vitro activity of tigemonam, a new monobactam.J Antimicrob Chemother. 1988 Sep;22(3):307-13. doi: 10.1093/jac/22.3.307. J Antimicrob Chemother. 1988. PMID: 3182428
-
In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.J Chemother. 1989 May;1 Suppl 2:32-5. J Chemother. 1989. PMID: 2809700
-
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1986 Feb;31(2):96-130. doi: 10.2165/00003495-198631020-00002. Drugs. 1986. PMID: 3512234 Review.
-
Discovery and development of the monobactams.Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S579-93. doi: 10.1093/clinids/7.supplement_4.s579. Rev Infect Dis. 1985. PMID: 3909315 Review.
Cited by
-
Selective decontamination in bone marrow transplant recipients.Epidemiol Infect. 1992 Dec;109(3):349-60. doi: 10.1017/s0950268800050342. Epidemiol Infect. 1992. PMID: 1468520 Free PMC article. Review.
-
Microbiome as mediator: Do systemic infections start in the gut?World J Gastroenterol. 2015 Oct 7;21(37):10487-92. doi: 10.3748/wjg.v21.i37.10487. World J Gastroenterol. 2015. PMID: 26457009 Free PMC article.
-
Optimal treatment of Imipenem and meropenem against bloodstream infections caused by the Citrobacter spp.BMC Infect Dis. 2025 Mar 17;25(1):366. doi: 10.1186/s12879-025-10760-6. BMC Infect Dis. 2025. PMID: 40091023 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources